<p>Scatterplot visualizing the EFV plasma concentrations from 36 patients with 182 samples and corresponding dose/weight. Linear regression with cluster robust standard errors: P-EFV (mg/L) = 4.34–0.0556*Dose/Weight (mg/kg/day); p = 0.36; r<sup>2</sup> = 0.0046.</p
OBJECTIVE: The reverse transcriptase inhibitor efavirenz is currently used at a fixed dose of 600 mg...
© 2017 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.Efavirenz (...
The aim of this study was to determine the utility of dried blood spots (DBS) compared with conventi...
<p>Triangles indicate cases with concurrent rifampicin use, and circles indicate cases without takin...
<p>Variation in the mean dose/weight (left) and EFV mean plasma concentration (right) in all include...
<p>Efavirenz concentrations at week 22 and week 50 in patients whose efavirenz concentrations >4,000...
<p>Distribution of efavirenz plasma concentrations according to the therapeutic range at each sampli...
<p>Comparison of efavirenz concentration between week 4 and week 16 with in Ethiopians and Tanzanian...
Background: Efavirenz is among the most widely used antiretroviral drugs. Increased efavirenz exposu...
<p>(A) Survival time according to molecular viral load at D7; (B) molecular viral load at D7 accordi...
The pharmacokinetics (PK) of efavirenz (EFV) is characterized by marked interpatient variability tha...
The pharmacokinetics (PK) of efavirenz (EFV) is characterized by marked interpatient variability tha...
Background: Pharmacogenetic studies have shown that slow and intermediate metabolizers of efavirenz...
We investigated the predictors of plasma mid-dose concentrations (C12) of efavirenz by enrolling 456...
Objective: The relationships between adverse events (AEs) and plasma concentrations of nevirapine (N...
OBJECTIVE: The reverse transcriptase inhibitor efavirenz is currently used at a fixed dose of 600 mg...
© 2017 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.Efavirenz (...
The aim of this study was to determine the utility of dried blood spots (DBS) compared with conventi...
<p>Triangles indicate cases with concurrent rifampicin use, and circles indicate cases without takin...
<p>Variation in the mean dose/weight (left) and EFV mean plasma concentration (right) in all include...
<p>Efavirenz concentrations at week 22 and week 50 in patients whose efavirenz concentrations >4,000...
<p>Distribution of efavirenz plasma concentrations according to the therapeutic range at each sampli...
<p>Comparison of efavirenz concentration between week 4 and week 16 with in Ethiopians and Tanzanian...
Background: Efavirenz is among the most widely used antiretroviral drugs. Increased efavirenz exposu...
<p>(A) Survival time according to molecular viral load at D7; (B) molecular viral load at D7 accordi...
The pharmacokinetics (PK) of efavirenz (EFV) is characterized by marked interpatient variability tha...
The pharmacokinetics (PK) of efavirenz (EFV) is characterized by marked interpatient variability tha...
Background: Pharmacogenetic studies have shown that slow and intermediate metabolizers of efavirenz...
We investigated the predictors of plasma mid-dose concentrations (C12) of efavirenz by enrolling 456...
Objective: The relationships between adverse events (AEs) and plasma concentrations of nevirapine (N...
OBJECTIVE: The reverse transcriptase inhibitor efavirenz is currently used at a fixed dose of 600 mg...
© 2017 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.Efavirenz (...
The aim of this study was to determine the utility of dried blood spots (DBS) compared with conventi...